| A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis (NCT01007435) | Hoffmann-La Roche | 2009-10-31 |
| Vanguard Rocc Post Market Surveillance (NCT03664791) | Zimmer Biomet | 2009-10-23 |
| A Study Of PF-04171327 In The Treatment Of The Signs And Symptoms Of Rheumatoid Arthritis (NCT00938587) | Pfizer | 2009-10-07 |
| A Study of CDP870 as Add-on Meditation to Methotrexate (MTX) in Patients With Rheumatoid Arthritis (NCT00993317) | Korea Otsuka Pharmaceutical Co., Ltd. | 2009-10-01 |
| Phase 1 Trial of Type II Collagen (CII) APL A12 in Rheumatoid Arthritis Patients (NCT01123655) | VA Office of Research and Development | 2009-10-01 |
| Improvement of a Physically Active Lifestyle (NCT00979719) | Freie Universität Berlin | 2009-10-01 |
| Vanguard Complete Knee Versus Vanguard High Flex Rotating Platform (RP) Knee Study (NCT01010269) | Zimmer Biomet | 2009-10-01 |
| Changes in the Use of Opioids, Antidepressants, and Benzodiazepines in Rheumatoid Arthritis Patients Treated With Biologic Agents (NCT01137838) | Bristol-Myers Squibb | 2009-10-01 |
| Success of Tocilizumab in RA Patients With Remission Induction and Sustained Efficacy After Discontinuation (NCT01120366) | SURPRISE Study Group | 2009-10-01 |
| Observation of Treatment With Certolizumab Pegol in Daily Practice (NCT01069419) | UCB Pharma GmbH | 2009-10-01 |
| Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis (NCT01211834) | JW Pharmaceutical | 2009-10-01 |
| Abatacept Versus Adalimumab Head-to-Head (NCT00929864) | Bristol-Myers Squibb | 2009-10-01 |
| Transplantation of Bone Marrow Derived Mesenchymal Stem Cells in Affected Knee Osteoarthritis by Rheumatoid Arthritis (NCT01873625) | Royan Institute | 2009-10-01 |
| Genetics and Mechanisms of Rheumatoid Arthritis (NCT01788098) | Slovak Academy of Sciences | 2009-10-01 |
| To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using Methotrexate (NCT01009242) | UCB Pharma | 2009-10-01 |
| Cell Immunity Response to Vaccination Against Influenza in Patients With Rheumatoid Arthritis (NCT01002716) | Tel-Aviv Sourasky Medical Center | 2009-10-01 |
| A Study of Tocilizumab in Combination With Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDs (NCT00996606) | Hoffmann-La Roche | 2009-10-01 |
| A Study for Japanese Participants With Rheumatoid Arthritis (RA) (NCT01253226) | Eli Lilly and Company | 2009-09-01 |
| Self-Directed Exercise Program for Adults With Arthritis (NCT01172327) | University of South Carolina | 2009-09-01 |
| An Observational Study on Patients With Rheumatoid Arthritis Treated With MabThera (Rituximab) (NCT01075477) | Hoffmann-La Roche | 2009-09-01 |
| Atherosclerosis in Rheumatoid Arthritis (NCT00990730) | University of California, San Francisco | 2009-09-01 |
| National Data Bank for Rheumatic Disease Registry Study of Safety in Patients With Rheumatoid Arthritis Treated With Cimzia® or Disease-modifying Antirheumatic Drugs (DMARDs) (NCT01095393) | UCB Pharma | 2009-09-01 |
| Lifestyle Interventions Based on the Mediterranean Diet for Patients With Rheumatoid Arthritis (NCT02028624) | Harokopio University | 2009-09-01 |
| Improving Beliefs About Medication in Patients With Rheumatoid Arthritis (NCT00968266) | Sint Maartenskliniek | 2009-09-01 |
| Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis (NCT00913458) | Pfizer | 2009-09-01 |
| Efficacy of Oncoxin Plus Viusid in the Treatment of Rheumatoid Arthritis (NCT00969527) | Catalysis SL | 2009-09-01 |
| Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines (NCT00993668) | UCB Pharma | 2009-09-01 |
| Targeting Synovitis in Early Rheumatoid Arthritis (NCT00920478) | NHS Greater Glasgow and Clyde | 2009-09-01 |
| Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment (NCT00984815) | Amgen | 2009-09-01 |
| Comparison of Three Different Treatment Regimes in Early Rheumatoid Arthritis: A Randomized Open-labelled Trial (NCT01870128) | All India Institute of Medical Sciences | 2009-08-01 |
| Rheumatology Clinical Registry (NCT01813409) | American College of Rheumatology | 2009-08-01 |
| Metasul Monoblock Component™ Cup in a Hip Resurfacing Application With the Durom® Hip Resurfacing Femoral Component (NCT03681639) | Zimmer Biomet | 2009-08-01 |
| A Study of Subcutaneously Administered Tocilizumab in Patients With Rheumatoid Arthritis (NCT00965653) | Hoffmann-La Roche | 2009-08-01 |
| Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to Methotrexate (NCT01224041) | Astellas Pharma Inc | 2009-08-01 |
| Retrospective Evaluation of the Radiographic Efficacy of Conventional and Biologic Treatment (NCT00929357) | Pfizer | 2009-08-01 |
| A Study in Patients With Rheumatoid Arthritis (NCT00966875) | Eli Lilly and Company | 2009-08-01 |
| A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Combination Therapy of T-614 and Methotrexate in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate (NCT00965757) | Eisai Co., Ltd. | 2009-07-31 |
| Rheumatoid Arthritis Coping Enhancement (NCT04246827) | Duke University | 2009-07-07 |
| An Observational Quality of Life Study in Participants With Rheumatoid Arthritis Treated With Rituximab (NCT02507752) | Hoffmann-La Roche | 2009-07-01 |
| Study of LX3305 in Subjects With Active Rheumatoid Arthritis on Stable Methotrexate (NCT00903383) | Lexicon Pharmaceuticals | 2009-07-01 |
| Efficacy, Safety and Tolerability of AIN457 in Patients With Rheumatoid Arthritis (RA) Taking Methotrexate (MTX) (NCT00928512) | Novartis Pharmaceuticals | 2009-07-01 |
| Draining PLN and Synovial Inflammation in RA Knee Joints Pre and Post Anti-TNF or B Cell Depletion Therapy (NCT01083563) | University of Rochester | 2009-07-01 |
| Study To Evaluate The Safety And Efficacy Of ILV-094 In Subjects With Rheumatoid Arthritis (NCT00883896) | Pfizer | 2009-06-18 |
| A Study of Tocilizumab With or Without Methotrexate in Patients With Rheumatoid Arthritis. (NCT01010503) | Hoffmann-La Roche | 2009-06-01 |
| Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) Therapy (NCT00848354) | Pfizer | 2009-06-01 |
| Iyengar Yoga for Young People With Rheumatoid Arthritis (NCT01096823) | University of California, Los Angeles | 2009-06-01 |
| Applications for Methotrexate Optimization in Rheumatoid Arthritis (NCT01038349) | Cypress Bioscience, Inc. | 2009-06-01 |
| Monitoring Epstein-Barr Virus (EBV) Load in Rheumatoid Arthritis Patients Treated With New Immunosuppressive Drugs (NCT00947492) | Assistance Publique Hopitaux De Marseille | 2009-06-01 |
| Standard Disease Activity Parameters and Step Activity in Patients With Rheumatoid Arthritis Receiving Etanercept (NCT01388608) | University Hospital Muenster | 2009-06-01 |
| First-in-man Trial of NNC0142-0002 in Patients With Rheumatoid Arthritis (NCT00927927) | Janssen Research & Development, LLC | 2009-06-01 |
| TORPEDO Study: A Study on Rapid Effect of Tocilizumab in Patients With Rheumatoid Arthritis With an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs) or Anti-TNF (NCT00977106) | Hoffmann-La Roche | 2009-06-01 |
| Participation Restrictions in Rheumatoid Arthritis (NCT02863653) | Federal University of Minas Gerais | 2009-06-01 |
| Activity Limitations in Rheumatoid Arthritis (NCT02730286) | Federal University of Minas Gerais | 2009-06-01 |
| An Observational Study of MabThera/Rituxan (Rituximab) and Alternative TNF-Inhibitors in Patients With Rheumatoid Arthritis and an Inadequate Response to a Single Previous TNF-Inhibitor (NCT01557348) | Hoffmann-La Roche | 2009-06-01 |
| Occupational Performance Problems in Individuals With Rheumatoid Arthritis (NCT02968745) | Federal University of Minas Gerais | 2009-06-01 |
| The Use of Neuromuscular Electrical Stimulation to Reverse Muscle Atrophy in Patients With Rheumatoid Arthritis (NCT00924625) | University of Pittsburgh | 2009-06-01 |
| Phase I Study Of The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Intravenously Administered Doses Of PF-04236921 In Patients With Rheumatoid Arthritis (NCT00838565) | Pfizer | 2009-05-20 |
| Economic Burden in Adult Patients Diagnosed With Rheumatoid Arthritis (RA) Receiving Treatment With Biologic Disease-modifying Antirheumatic Drugs (bDMARDs) (NCT01136694) | Bristol-Myers Squibb | 2009-05-01 |
| A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis (NCT00853385) | Pfizer | 2009-05-01 |
| A Study Comparing Infusion Rates of Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis (NCT00887341) | Hoffmann-La Roche | 2009-05-01 |
| INCB028050 Compared to Background Therapy in Patients With Active Rheumatoid Arthritis (RA) With Inadequate Response to Disease Modifying Anti-Rheumatic Drugs (NCT00902486) | Incyte Corporation | 2009-05-01 |
| A Study of the Safety and Pharmacokinetics of PRO283698 in Patients With Rheumatoid Arthritis (NCT00888745) | Genentech, Inc. | 2009-05-01 |
| Evaluation by HR-pQCT of Bone Microarchitecture Changes in Patients With Rheumatoid Arthritis Under Anti-TNF Therapy. (NCT02526992) | Centre Hospitalier Universitaire de Saint Etienne | 2009-05-01 |
| Comparison of the Tuberculin Skin Test (TST) and QuantiFERON ®-TB Gold Test (QFT-G) In Patients With Rheumatoid Arthritis Being Considered for Anti-TNF-Alpha Therapy (NCT00925249) | Walter Reed Army Medical Center | 2009-05-01 |
| A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs) (NCT00891020) | Hoffmann-La Roche | 2009-05-01 |
| A Study to Assess the Pharmacokinetics of Methotrexate Given With and Without AZD9056 in Rheumatoid Arthritis Patients (NCT00920608) | AstraZeneca | 2009-05-01 |
| Golimumab Safety and Surveillance Program Using the Ingenix NHI Database (NCT01081717) | Janssen Biotech, Inc. | 2009-04-14 |
| Dose Ranging Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate (NCT00928317) | Arana Therapeutics Ltd | 2009-04-01 |
| A Study to Investigate the Potential for AZD5672 to Affect the Electrical Conduction Pathways in the Heart (NCT00887770) | AstraZeneca | 2009-04-01 |
| Expanded Access Trial of Belimumab Antibody in RA Patients Who Were Previously Treated Under HGS Protocol LBRA99 (NCT00931086) | Human Genome Sciences Inc., a GSK Company | 2009-04-01 |
| Investigating the Impact of Mode of Administration on Item Response (NCT00783991) | Stony Brook University | 2009-04-01 |
| Inflammation and Insulin Resistance in Rheumatoid Arthritis (NCT00763139) | Vanderbilt University | 2009-04-01 |
| Role of Greyscale and Power Doppler Sonography in Therapy Monitoring in Early Rheumatoid Arthritis (RA) (NCT00854243) | Cairo University | 2009-04-01 |
| A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or Adalimumab (NCT00808210) | Genentech, Inc. | 2009-03-05 |
| A Study of Combination Treatment With MabThera (Rituximab) and RoActemra (Tocilizumab) Versus RoActemra in Patients With Rheumatoid Arthritis With an Incomplete Response to Methotrexate (NCT00845832) | Hoffmann-La Roche | 2009-03-01 |
| Evaluation of the Role of Adalimumab on Extraarticular Manifestation - Bone Metabolism and Bone Mineral Density in Patients With Active Rheumatoid Arthritis (NCT01078155) | AbbVie (prior sponsor, Abbott) | 2009-03-01 |
| Assessment of Wrist Joint and Knee Joint Inflammation in Patients With Rheumatoid Arthritis by Quantitative Three Dimensional Power Doppler Ultrasonography (NCT00858169) | Taichung Veterans General Hospital | 2009-03-01 |
| A Study of Tocilizumab and Methotrexate Treatment Strategies (Adding Tocilizumab to Methotrexate Versus Switching to Tocilizumab) in Patients With Active Rheumatoid Arthritis With Inadequate Response to Prior Methotrexate Treatment (NCT00810199) | Hoffmann-La Roche | 2009-03-01 |
| A Study of Adalimumab in Japanese Subjects With Rheumatoid Arthritis (NCT00870467) | Abbott | 2009-03-01 |
| Efficacy and Safety Study of RoActemra (Tocilizumab) in Participants With Rheumatoid Arthritis (NCT02721004) | Hoffmann-La Roche | 2009-03-01 |
| Long-term Treatment Study of Certolizumab Pegol Without Coadministration of Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients (NCT00850343) | Astellas Pharma Inc | 2009-03-01 |
| Long-term Treatment Study of Certolizumab Pegol (CDP870) as Add-on Medication to Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients (NCT00851318) | Astellas Pharma Inc | 2009-03-01 |
| AZD5672 Bioavailability Study in Healthy Male and Female Subjects (NCT00871767) | AstraZeneca | 2009-03-01 |
| Patient Rheumatoid Arthritis Social Support Study (NCT01525654) | Brigham and Women's Hospital | 2009-03-01 |
| Observational Safety Study of Rituximab in Patients Diagnosed With Rheumatoid Arthritis (RA) Who Did Not Respond Adequately to TNF-alpha Blocker (NCT02322801) | Hoffmann-La Roche | 2009-03-01 |
| Study Evaluating Impact of the Use of a Computer-based Tool on the Clinical Management of RA Patients (NCT00895050) | Pfizer | 2009-03-01 |
| An Extension to Study MA21573, Evaluating Tocilizumab in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biological DMARDs and/or Anti-tumor Necrosis Factor (TNF) Therapy (NCT00883753) | Hoffmann-La Roche | 2009-03-01 |
| Post-Market Study of the 3DKnee™ System (NCT00819481) | Encore Medical, L.P. | 2009-02-01 |
| Dose Optimisation Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate (NCT00854685) | Arana Therapeutics Ltd | 2009-02-01 |
| A Study to Assess the Effect of Tocilizumab Plus Methotrexate on Safety and Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis (NCT00754572) | Hoffmann-La Roche | 2009-02-01 |
| Study of LX3305 and Methotrexate in Subjects With Stable Rheumatoid Arthritis (NCT00847886) | Lexicon Pharmaceuticals | 2009-02-01 |
| Effectiveness of Water Exercises on Isokinetic Muscle Strength (NCT01447264) | Federal University of São Paulo | 2009-02-01 |
| An Open Label Extension Study in Participants With Rheumatoid Arthritis (NCT00837811) | Eli Lilly and Company | 2009-02-01 |
| BTT-1023 in Rheumatoid Arthritis (NCT00851240) | Biotie Therapies Corp. | 2009-02-01 |
| Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Active, Stable, Moderate to Severe Rheumatoid Arthritis (NCT00777816) | XOMA (US) LLC | 2009-02-01 |
| Effectiveness in Daily Practice of Different Treatment Strategies for Early Rheumatoid Arthritis. (NCT01172639) | P. Verschueren | 2009-02-01 |
| Safety and Effect on Quality of Life/Work Productivity of Humira in Patients With Rheumatoid Arthritis (NCT01076205) | AbbVie (prior sponsor, Abbott) | 2009-01-12 |
| Rheumatoid Arthritis Disease Activity Monitor (NCT00989677) | Maxima Medical Center | 2009-01-01 |
| Follow-up of Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study (NCT00843778) | UCB Pharma | 2009-01-01 |
| RETRO (REduction of Therapy in RA Patients in Ongoing Remission) (NCT02779114) | University of Erlangen-Nürnberg Medical School | 2009-01-01 |